Skip Navigation


Human Molecular Genetics Advance Access originally published online on September 10, 2009
Human Molecular Genetics 2009 18(23):4629-4639; doi:10.1093/hmg/ddp430
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
18/23/4629    most recent
ddp430v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Giovannone, B.
Right arrow Articles by Smith, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giovannone, B.
Right arrow Articles by Smith, R. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling

Barbara Giovannone1, William G. Tsiaras1, Suzanne de la Monte2, Jan Klysik3, Corinne Lautier1,{dagger}, Galina Karashchuk1, Stefano Goldwurm4 and Robert J. Smith1,*

1 Division of Endocrinology and 2 Liver Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI 02903, USA, 3 Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA and 4 Parkinson Institute, Istituti Clinici di Perfezionamento, Milan 20126, Italy

* To whom correspondence should be addressed at: Division of Endocrinology, Rhode Island Hospital, One Hoppin Street, Suite 200, Providence, RI 02903, USA. Tel: +1 4014443420; Fax: +1 4014444921; Email: rsmith4{at}lifespan.org

Received June 19, 2009; Revised August 25, 2009; Accepted September 7, 2009

Grb10-Interacting GYF Protein 2 (GIGYF2) was initially identified through its interaction with Grb10, an adapter protein that binds activated IGF-I and insulin receptors. The GIGYF2 gene maps to human chromosome 2q37 within a region linked to familial Parkinson's disease (PARK11 locus), and association of GIGYF2 mutations with Parkinson's disease has been described in some but not other recent publications. This study investigated the consequences of Gigyf2 gene disruption in mice. Gigyf2 null mice undergo apparently normal embryonic development, but fail to feed and die within the first 2 post-natal days. Heterozygous Gigyf2+/– mice survive to adulthood with no evident metabolic or growth defects. At 12–15 months of age, the Gigyf2+/– mice begin to exhibit motor dysfunction manifested as decreased balance time on a rotating horizontal rod. This is associated with histopathological evidence of neurodegeneration and rare intracytoplasmic Lewy body-like inclusions in spinal anterior horn motor neurons. There are {alpha}-synuclein positive neuritic plaques in the brainstem and cerebellum, but no abnormalities in the substantia nigra. Primary cultured embryo fibroblasts from Gigyf2 null mice exhibit decreased IGF-I-stimulated IGF-I receptor tyrosine phosphorylation and augmented ERK1/2 phosphorylation. These data provide further evidence for an important role of GIGYF2 in age-related neurodegeneration and IGF pathway signaling.


{dagger} Present address: Universite Montpellier II, Montpellier, France.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.